Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Pain 3Neoplasms 3Cancer Pain 2Neuralgia 1Breast Neoplasms 1

Interventions

Morphine 11Oxycodone 8Fentanyl 6nabiximols 5Methadone 4Hydromorphone 4Acetaminophen 3Transcutaneous Electric Nerve Stimulation 2Tapentadol 2Naloxone 2Lidocaine 2Buprenorphine 2Acupuncture Therapy 2tanezumab 1resiniferatoxin 1oxycodone naloxone combination 1fulranumab 1cannabichromene 1alvimopan 1Water 1Ultracet 1Transcranial Direct Current Stimulation 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tablets 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Cancer Pain × Tapentadol × Clear all
NCT00472303 2019-11-04

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Grünenthal GmbH

Phase 3 Completed
622 enrolled 31 charts

Cancer Pain, Neoplasms, Pain

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡